Trial intelligence / Profile preview

Plinabulin vs pegfilgrastim to prevent chemotherapy‑induced neutropenia in breast cancer

CTR20182252Phase 3Completed

Sponsor
BeyondSpring Inc.
Start
Sep 2019
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of plinabulin in neutropenia, sponsored by BeyondSpring Inc.. Started Sep 2019; status: completed.

02

Drugs

plinabulin
03

Conditions

neutropenia

Beyond the preview

Go deeper on CTR20182252.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on CTR20182252.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call